Multifunctional hydrogels based on chitosan, hyaluronic acid and other biological macromolecules for the treatment of inflammatory bowel disease: A review

被引:76
|
作者
Ouyang, Yongliang [1 ]
Zhao, Jiulong [2 ]
Wang, Shige [1 ]
机构
[1] Univ Shanghai Sci & Technol, Sch Mat & Chem, 516 Jungong Rd, Shanghai 200093, Peoples R China
[2] Naval Med Univ, Changhai Hosp, Dept Gastroenterol, 168 Changhai Rd, Shanghai 200433, Peoples R China
关键词
Multifunctional hydrogels; Inflammatory bowel disease; Chitosan; Hyaluronic acid; Biological macromolecules; MESOPOROUS SILICA NANOPARTICLES; NEGATIVELY CHARGED LIPOSOMES; REGULATORY T-CELLS; DRUG-DELIVERY; ULCERATIVE-COLITIS; OXIDATIVE STRESS; COLONIC-MUCOSA; ORAL DELIVERY; THERAPY; PATHOGENESIS;
D O I
10.1016/j.ijbiomac.2022.12.032
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Hydrogel is a three-dimensional network polymer material rich in water. It is widely used in the biomedical field because of its unique physical and chemical properties and good biocompatibility. In recent years, the incidence of inflammatory bowel disease (IBD) has gradually increased, and the disadvantages caused by traditional drug treatment of IBD have emerged. Therefore, there is an urgent need for new treatments to alleviate IBD. Hydrogel has become a potential therapeutic platform. However, there is a lack of comprehensive review of functional hydrogels for IBD treatment. This paper first summarizes the pathological changes in IBD sites. Then, the action mechanisms of hydrogels prepared from chitosan, sodium alginate, hyaluronic acid, functionalized polyethylene glycol, cellulose, pectin, and gamma-polyglutamic acid on IBD were described from aspects of drug delivery, peptide and protein delivery, biologic therapies, loading probiotics, etc. In addition, the advanced functions of IBD treatment hydrogels were summarized, with emphasis on adhesion, synergistic therapy, pH sensitivity, particle size, and temperature sensitivity. Finally, the future development direction of IBD treatment hydrogels has been prospected.
引用
收藏
页码:505 / 523
页数:19
相关论文
共 50 条
  • [31] Review article: biological activity markers in inflammatory bowel disease
    Desai, D.
    Faubion, W. A.
    Sandborn, W. J.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2007, 25 (03) : 247 - 255
  • [32] Combined Treatment with Hyaluronic Acid and Mesalamine Protects Rats from Inflammatory Bowel Disease Induced by Intracolonic Administration of Trinitrobenzenesulfonic Acid
    Chiu, Chih-Tung
    Kuo, Sheng-Nan
    Hung, Shao-Wen
    Yang, Cheng-Yao
    MOLECULES, 2017, 22 (06)
  • [33] Chitosan and hyaluronic acid based injectable dual network hydrogels - Mediating antimicrobial and inflammatory modulation to promote healing of infected bone defects
    Wang, Shang
    Lei, Huan
    Mi, Yu
    Ma, Pei
    Fan, Daidi
    INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 2024, 274
  • [34] Synthesis and biological evaluation of chrysin derivatives containing α-lipoic acid for the treatment of inflammatory bowel disease
    Zhao, Pengyu
    Hou, Yusen
    Yan, Tingting
    Kang, Jie
    Tian, Ye
    Li, Jiaxin
    Zeng, Chenjuan
    Geng, Funeng
    Liao, Qi
    FRONTIERS IN CHEMISTRY, 2024, 12
  • [35] Licochalcone A loaded multifunctional chitosan hyaluronic acid hydrogel with antibacterial and inflammatory regulating effects to promote wound healing
    Hou, Zhiquan
    Wang, Yahong
    Chen, Siqi
    Luo, Zhonghua
    Liu, Yunen
    INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 2024, 283
  • [36] Economic optimization of biological therapy in the treatment of inflammatory bowel disease
    Valle Diaz de la Guardia, Ana Maria
    Lorente Macias, Alvaro
    Ruiz Fuentes, Salvador
    Cabeza Barrera, Jose
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2015, 37 (01) : 271 - 271
  • [37] Must immunomodulators be added to biological treatment in inflammatory bowel disease?
    Gomollon, Fernando
    Gisbert, Javier P.
    GASTROENTEROLOGIA Y HEPATOLOGIA, 2010, 33 (01): : 43 - 53
  • [38] Profits from biological treatment in inflammatory bowel disease patients
    Dobrowolska-Zachwieja, Agnieszka
    Jakubowska-Burek, Ludwika
    PRZEGLAD GASTROENTEROLOGICZNY, 2010, 5 (02): : 68 - 76
  • [39] Adverse efffects in patients with Inflammatory Bowel Disease on biological treatment
    Ramirez de la Piscina, P.
    Urtasun, L.
    Duca, I. M.
    Spicakova, K.
    Ganchegui, I.
    Campos, A.
    Sanchez, A.
    Estrada, S.
    Calderon, M. D. R.
    Salvador, M.
    Delgado, E.
    JOURNAL OF CROHNS & COLITIS, 2015, 9 : S380 - S380
  • [40] Risk of infections associated with biological treatment in inflammatory bowel disease
    Nynne Nyboe Andersen
    Tine Jess
    World Journal of Gastroenterology, 2014, (43) : 16014 - 16019